ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01330966
Recruitment Status : Completed
First Posted : April 7, 2011
Last Update Posted : March 23, 2018
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Vector Oncology

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2018
  Actual Study Completion Date : February 2018